182 related articles for article (PubMed ID: 23834905)
1. Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation.
Takeuchi M; Urano M; Hara M; Fujiyoshi Y; Inagaki H; Shibamoto Y
Clin Imaging; 2013; 37(5):908-12. PubMed ID: 23834905
[TBL] [Abstract][Full Text] [Related]
2. MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types.
Takeuchi M; Kawai T; Suzuki T; Naiki T; Kawai N; Fujiyoshi Y; Inagaki H; Kohri K; Hara M; Shibamoto Y
Abdom Imaging; 2015 Jan; 40(1):112-9. PubMed ID: 24965897
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation.
Takeuchi M; Froemming AT; Kawashima A; Thapa P; Carter RE; Cheville JC; Thompson RH; Takahashi N
Abdom Radiol (NY); 2022 Jun; 47(6):2168-2177. PubMed ID: 35381868
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material.
Akita H; Jinzaki M; Akita A; Mikami S; Oya M; Kuribayashi S
J Magn Reson Imaging; 2014 Apr; 39(4):924-30. PubMed ID: 24123320
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
6. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
Park JJ; Kim CK
AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI of solid renal masses: pearls and pitfalls.
Ramamurthy NK; Moosavi B; McInnes MD; Flood TA; Schieda N
Clin Radiol; 2015 Mar; 70(3):304-16. PubMed ID: 25472466
[TBL] [Abstract][Full Text] [Related]
8. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
9. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
[TBL] [Abstract][Full Text] [Related]
10. MRI findings of sarcomatoid renal cell carcinoma in nine cases.
Rosenkrantz AB; Chandarana H; Melamed J
Clin Imaging; 2011; 35(6):459-64. PubMed ID: 22040791
[TBL] [Abstract][Full Text] [Related]
11. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.
Akita H; Jinzaki M; Kikuchi E; Sugiura H; Akita A; Mikami S; Kuribayashi S
AJR Am J Roentgenol; 2011 Nov; 197(5):1130-6. PubMed ID: 22021505
[TBL] [Abstract][Full Text] [Related]
12. Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma.
Li H; Liang L; Li A; Hu Y; Hu D; Li Z; Kamel IR
J Magn Reson Imaging; 2017 Jul; 46(1):240-247. PubMed ID: 27859853
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of subtypes of renal cell carcinoma: dynamic contrast-enhanced magnetic resonance imaging versus diffusion-weighted magnetic resonance imaging.
Yamamoto A; Tamada T; Ito K; Sone T; Kanki A; Tanimoto D; Noda Y
Clin Imaging; 2017; 41():53-58. PubMed ID: 27816876
[TBL] [Abstract][Full Text] [Related]
14. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
[TBL] [Abstract][Full Text] [Related]
16. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
17. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T.
Manenti G; Di Roma M; Mancino S; Bartolucci DA; Palmieri G; Mastrangeli R; Miano R; Squillaci E; Simonetti G
Radiol Med; 2008 Mar; 113(2):199-213. PubMed ID: 18386122
[TBL] [Abstract][Full Text] [Related]
18. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
19. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
